Rhegmatogenous Retinal Detachment Following Intravitreal Ranibizumab Injection in Myopic Choroidal Neovascularization Patient

Jee, Donghyun; Kong, Suk Joon; Ra, Tae Yoon

Case Report

Korean Journal of Optometry and Vision Science 2010;9(2):58-61.
Published online December 20, 2010.

근시성 맥락막 신생혈관 환자에서 유리체내 라니비주맙 주입술 후 발생한 열공망막박리

지동현, 공석준, 나태윤

Department of Ophthalmology and Visual Science, College of Medicine, The Catholic University of Korea, Seoul, Korea

Rhegmatogenous Retinal Detachment Following Intravitreal Ranibizumab Injection in Myopic Choroidal Neovascularization Patient

Donghyun Jee, Suk Joon Kong, Tae Yoon Ra

Abstract

Purpose
To report a case of rhegmatogenous retinal detachment following intravitreal ranibizumab injection in the treatment of myopic choroidal neovascularization (CNV) with pathologic high myopia. Methods: A 44 year old woman was diagnosed with myopic CNV and treated with intravitreal ranibizumab injection. Results: The patient developed a sudden decline in vision two weeks after the injection, and was subsequently diagnosed with rhegmatogenous retinal detachment. She underwent standard three-port pars plana vitrectomy with silicone oil injection. The macular was still attached, but subretinal fluid was remained at the inferior peripheral retina at the patient's final follow-up visit. Conclusions: Intravitreal ranibizumab injection used for the treatment of myopic CNV can be associated with rhegmatogenous retinal detachment. Patients need to be informed about this potential complication, and higher suspicion is needed in patients who report sudden vision loss after the treatment. (Korean J Optom Vis Sci 2010;9(2):58-61)

Key Words: Myopic choroidal neovascularization, Ranibizumab, Rhegmatogenous retinal detachment